Long Term Results of Bronchial Sleeve Resection for Primary Lung Cancer.
- Author:
Suk Ki CHO
1
;
Ki Ick SUNG
;
Cheul LEE
;
Jae Ik LEE
;
Joo Hyun KIM
;
Young Tae KIM
;
Sook Whan SUNG
Author Information
1. Department of Thoracic, Seoul National University College of Medicine, Seoul, Korea.
- Publication Type:Original Article
- Keywords:
Sleeve resection;
Lung neoplasm;
Lung surgery
- MeSH:
Adenocarcinoma;
Bronchoscopy;
Carcinoma, Squamous Cell;
Chylothorax;
Constriction, Pathologic;
Female;
Follow-Up Studies;
Hospital Mortality;
Humans;
Lung Neoplasms*;
Lung*;
Male;
Pleural Effusion;
Pneumonectomy;
Pneumonia;
Postoperative Complications;
Pulmonary Atelectasis;
Seoul;
Survival Rate;
Thoracic Surgery
- From:The Korean Journal of Thoracic and Cardiovascular Surgery
2001;34(12):917-923
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
BACKGROUND: Bronchial sleeve resection for centrally located primary lung cancer is a lung- parenchyma-sparing operation in patients whose predicted postoperative lung function is expected to diminished markedly. Because of its potential bronchial anastomotic complications, it is considered to be an alternative to pneumonectomy. However, since sleeve lobectomy yielded survival results equal to at least those of pneumonectomy, as well as better functional results, it became and accepted standard procedure for patients with lung cancer who have anatomically suitable tumors, regardless of lung function. In this study, from analyzing of occurrence rate of postoperative complication and survival rate, we wish to investigate the validity of sleeve resection for primary lung cancer. MATERIAL AND METHOD: From January 1989 to December 1998, 45 bronchial sleeve resections were carried out in the Department of Thoracic Surgery of Seoul National University Hospital. We included 40 men and 5 women, whose ages ranged from 23 to 72 years with mean age of 57 years. Histologic type was squamous cell carcinoma in 35 patients, adenocarcinoma in 7, and adenosquamous cell carcinoma in 1 patients. Right upper lobectomy was performed in 24 patients, left upper lobectomy in 11, left lower lobectomy in 3, right lower lobectomy in 1, right middle lobecomy and right lower lobectomy in 3, right upper lobectomy and right middle lobecomy in 2, and left pneumonectomy in 1 patient. Postoperative stage was Ib in 11, IIa in 3, IIb in 16, IIIa in 13, and IIIb in 2 patients. RESULT: Postoperative complications were as follows; atelectasis in 9, persistent air leakage for more than 7 days was in 7 patients, prolonged pleural effusion for more than 2 weeks in 7, pneumonia in 2, chylothorax in 1, and disruption of anastomosis in 1. Hospital mortality was in 3 patients. During follow-up period, bronchial stricture at anastomotic site were found in 7 patients under bronchoscopy. Average follow-up duration of survivals(n=42) was 35.5+/-29 months. All of stage I patients were survived, and 3 year survival rate of stage II and III patients were 63%, 21%, respectively. According to N stage, all of N0 patients were survived and 3 year survival rates of N1 and N2 were 63% and 28% respectively. CONCLUSION: We suggest that this sleeve resection, which is technically demanding, should be considered in patients with centrally located lung cancer, because this lung-saving operation is safer than pneumonectomy and is equally curative.
